La bourse est fermée

The global HLA typing market is projected to reach USD 1.7 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 5.9%

ReportLinker

Growth in the HLA typing market is mainly driven by factors such as the increasing number of HLA typing procedures conducted, technological advancements in the field of HLA typing, and increasing funding for research.

New York, March 18, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "HLA Typing Market by Technology, Product, Application, End User - Global Forecast to 2025" - https://www.reportlinker.com/p05875819/?utm_source=GNW


Reagents & consumables accounted for the largest market share in 2019.
Based on product and service, the HLA typing market is segmented into reagents & consumables, instruments, and software & services.The reagents & consumables segment accounted for the largest share of the HLA typing market in 2019.

This can be attributed to the growing application horizons of molecular assay techniques in HLA typing, increasing patient emphasis on effective and early patient profiling during organ transplantation, the growing adoption of molecular diagnostic techniques in research studies, and the rising number of target procedures across major markets.

The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019.
On the basis of technology, the HLA typing market is segmented into molecular and non-molecular assay technologies.The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019.

The growth of this segment is attributed to their benefits over non-molecular assays, such as low turnaround times, high procedural efficacy, multi-sample study capabilities, and real-time sample analysis.

The diagnostic applications segment accounted for the largest share of the HLA typing market in 2019.
Based on application, the HLA typing market is segmented into diagnostic and research applications.The diagnostic applications segment dominates the HLA typing market.

This is attributed to technological advancements in molecular assay techniques, the increasing adoption of molecular assay procedures for pathogen encounter detection and histocompatibility cross-matching, and the growing incidence of chronic and infectious diseases.

The commercial service providers segment accounted for the largest share of the HLA typing market in 2019.
The HLA typing market, by end user, is segmented into commercial service providers, hospitals & surgical centers, and research laboratories & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the HLA typing market due to the ongoing rapid modernization and adoption of automation in HLA typing, growing outsourcing of R&D activities to said providers, and the increasing consolidation of diagnostic laboratories.

North America accounted for the largest share of the global HLA typing market in 2019.
The HLA typing market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.North America accounted for the largest share of the global HLA typing market in 2019.

This is majorly attributed to the high adoption of advanced diagnostic technologies, increasing prevalence of target diseases in the US and Canada, and technological advancements. The rising geriatric population and growing funding and support for research are other major factors driving the growth of this regional segment.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 (42%), Tier 2 (28%), and Tier 3 (30%)
• By Designation: C-level (76%), Director-level (10%), and Others (14%)
• By Region: North America (40%), Europe (30%), APAC (22%), LATAM (6%), and the MEA (2%)

The major players operating in the HLA typing market include Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Illumina, Inc. (US), Immucor, Inc. (US), CareDx (US), Becton, Dickinson and Company (US), and Hologic (US).

Research Coverage
This report studies the HLA typing market based on product and service, technology, applications, end user, and region.The report also studies the major factors affecting market growth, such as drivers, restraints, opportunities, and challenges.

In addition, it analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions.

Key Benefits of Buying the Report
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses better and make suitable go-to-market strategies.

This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, opportunities, and challenges.
Read the full report: https://www.reportlinker.com/p05875819/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001